Mochida Pharmaceutical Co (TSE:4534) EV-to-EBIT : 15.19 (As of Apr. 29, 2024)

View and export this data going back to 1963. Start your Free Trial

What is Mochida Pharmaceutical Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mochida Pharmaceutical Co's Enterprise Value is 円68,087 Mil. Mochida Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円4,481 Mil. Therefore, Mochida Pharmaceutical Co's EV-to-EBIT for today is 15.19.

The historical rank and industry rank for Mochida Pharmaceutical Co's EV-to-EBIT or its related term are showing as below:

TSE:4534' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.65 Med: 8.39 Max: 17.88
Current: 15.19

During the past 13 years, the highest EV-to-EBIT of Mochida Pharmaceutical Co was 17.88. The lowest was 3.65. And the median was 8.39.

TSE:4534's EV-to-EBIT is ranked better than
57.63% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.21 vs TSE:4534: 15.19

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Mochida Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円72,762 Mil. Mochida Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円4,481 Mil. Mochida Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.16%.

Mochida Pharmaceutical Co EV-to-EBIT Historical Data

The historical data trend for Mochida Pharmaceutical Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co EV-to-EBIT Chart

Mochida Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

14.07

11.39

8.39

5.37

6.80

Mochida Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															5.62	6.80	8.96	9.18	16.24

Competitive Comparison of Mochida Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mochida Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's EV-to-EBIT falls into.

Mochida Pharmaceutical Co EV-to-EBIT Calculation

Mochida Pharmaceutical Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	68086.996	/	4481
	=	15.19

Mochida Pharmaceutical Co's current Enterprise Value is 円68,087 Mil.
Mochida Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,481 Mil.

Mochida Pharmaceutical Co (TSE:4534) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mochida Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	4481	/	72761.693
	=	6.16 %

Mochida Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円72,762 Mil.
Mochida Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,481 Mil.

Mochida Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mochida Pharmaceutical Co (TSE:4534) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (TSE:4534) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845

Website

http://www.mochida.co.jp

Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (TSE:4534) Headlines

No Headlines